CE Credit Information

*Please note that the deadline has passed to claim credit for ASLMS 2025.

ASLMS 2025 Annual Conference
Orlando, FL
April 24-26, 2025

Maximum Credits:
12.25 / AMA PRA Category 1 Credit ™
12.5 / ANCC Credit Hours
14.7 / Contact Hours (CBRN)

Activity Overview

The ASLMS Annual Conference is the largest U.S. event focused on laser and energy-based medical technologies. It brings together experts from various fields to share knowledge, present research, and explore new clinical applications. The conference's unique focus on technology rather than a single specialty fosters interdisciplinary collaboration and innovation in patient care.

Target Audience

This activity is designed for an audience of physicians and other healthcare professionals interested in the use of lasers, energy-based devices, and related technologies across various specialties.

Learning Objectives

Upon completion of the educational activity, participants should be able to:

Outline the new basic science and clinical research in lasers and energy devices that may lead to novel therapeutic strategies.
Select appropriate laser and energy device therapies for specific patient problems.
Evaluate adverse events associated with clinical laser treatments.
Cite 2-3 strategies for collaborating with patients to develop treatment plans that meet their physical and emotional needs.

Hair Growth and Restoration

Identify appropriate candidate selection for hair transplant surgery.
Identify low level and high energy light therapy and medication options for hair growth.

Clinical Endpoints

Understand clinical endpoints and indicators.
Discuss therapeutic and warning endpoints for laser and energy-based devices.

Principles of Photobiomodulation

Explain the mechanisms of action of photobiomodulation (PBM).
Assess validation data for PBM devices.
Describe PBM applications in dermatology.

Optimizing Results with Ablative Resurfacing

Identify the advantages and disadvantages of ablative resurfacing.
Discuss how to implement ablative resurfacing in your practice.

Clinical Pearls: Genitourinary Health

Review the pathogenesis, disorders, treatment options, and standard of care for genitourinary health.
Develop knowledge, competence, and performance in laser and energy-based treatments for genitourinary health to provide safe, effective patient care in their own clinics.

Medical Applications for Lasers and Energy-Based Devices

Review varied approaches used with the devices.
Define safety techniques to maximize patient outcomes.
Identify how to select the appropriate laser or device in different clinical settings.

Complications

Recognize complications at the earliest possible moment.
Discuss how to minimize the risk of these complications occurring.

Advanced Tissue Tightening and Lifting

Investigate the clinical evidence and controversy surrounding current skin tightening technologies.
Examine effective techniques for patient assessment for various devices and how to set proper patient expectations during the consultation.
Evaluate practical treatment strategies that combine synergistic non-surgical therapies with or without injectables and topical therapy to enhance efficacy over time.
Review treatment solutions and counseling that optimizes both patient results and satisfaction (including criteria for surgical referral).

PLENARY: Parade of Specialties

Evaluate recent advancements in lasers and optical technologies across key biomedical fields through research and clinical applications.

Lasers and Litigation

Review how to manage the emotional impact of lawsuits and focus on strategies for success.

Fun with Fractional

Apply new timing and techniques to enhance surgical outcomes.
Implement advanced timing and techniques for improved cosmetic results.
Utilize optimized timing and techniques to enhance pediatric outcomes.

Early Career Pearls

Discuss how to navigate common early career pitfalls.
Review and apply key strategies for a successful early career phase.

PDT and Treatment of Skin Cancer with EBD

Understand and apply lasers and light to treat and prevent skin malignancies.
Review how to treat patients with select types of keratinocyte cancers and premalignancies in their own clinics.
Review how to treat patients in safe manners in their own clinics.
Discuss the evolving role of AI in diagnosing skin cancer and its potential for non-invasive diagnostics.

Clinical Pearls: Pediatrics

Discuss the benefits/limitations of laser, including which patients are likely to be responsive and those who are more likely to be treatment resistant.
Review what other options might come next in the field.

Advanced Vascular (Case-Based)

Illustrate unique approaches to management of complex vascular cases.
Discuss potential complications of various treatment approaches.
Place newer techniques into the context of standard patient management.
Review treatment alternatives to the management of complex vascular conditions.

Advanced Treatment of Scars

Develop and implement evidence-based scar treatment algorithms, including multi-modality approaches, to optimize patient outcomes and address the deficit in available scar treatment.
Identify and apply advanced techniques and coding strategies for scar treatment, with a focus on addressing the unique challenges of treating scars in patients with skin of color and leveraging emerging technologies.

What Could Possibly Go Wrong?

Apply knowledge of facial anatomy to avoid complications from lasers, EBD’s, and cosmetic injections.
Recognize symptoms associated with vascular occlusions from filler injections and current treatment paradigms.
Understand the best practices to ensure safe treatment in the periocular area with lasers and EBD’s, as well as safety with topical anesthetics.

Best Practices for Skin of Color

Identify safe and effective methods for using devices to treat patients with skin color, supported by case examples.
Describe strategies for avoiding and addressing complications when using energy-based devices on skin of color.
State key points for counseling patients with skin color on realistic expectations, challenges, access, and financial considerations.

Practice Management Pearls

Identify key strategies for building a successful cosmetic energy-based practice.
Describe effective methods for incorporating social media into your practice.

Laser Safety and Anesthesia

Develop knowledge of laser tissue interactions, anesthesia delivery methods, and techniques to prevent injuries to both operators and patients.
List strategies to protect both operators and patients from vaporized plume particles.
Discuss detailed knowledge of office-based safety features to prevent injuries.

Transdermal Drug Delivery

Understand and apply the concept of laser / EBD-assisted drug uptake.
Review how to treat patients with specific diagnoses / needs in their own clinics.
Discuss how to treat patients in safe manners in their own clinics.

Periorbital Rejuvenation

Identify safe treatment modalities for treating the periorbital area.

Optimizing Outcomes: Combining Energy-Based Devices and Injectables

Identify and apply multiple modalities to address patients' aesthetic needs.
Review the safest and most effective treatment sequences for combining aesthetic procedures.

Advanced Treatment of Pigmentation and Tattoos

Explain basic laser-tissue interactions and be able to apply this understanding to the evaluation of clinical therapeutic endpoints.
List multiple different treatment options/technologies and be able to identify the most appropriate 1-3 options for any given clinical situation.
State the appropriate endpoint for the use of laser for the treatment of pigmentary condition in skin of color.
Recognize potential issues using laser to treat pigmentary conditions in SOC.
Review how to deal with complications.

Advanced Ablative Resurfacing

Review the difference between Erbium and Co2 laser resurfacing.
Discuss the new Standard of Care in regard to ablative laser resurfacing.
Recognize the difference in Erbium wavelengths.
List the ways ablative technology can be utilized, specifically in full field, fractional, and laser-coring.

Advanced Body Contouring, Lifting, Tightening

Identify how to streamline the evaluation and treatment process of patients to achieve better patient outcomes.
Review various technologies (lasers, cryolipolysis, radiofrequency, ultrasound) for fat removal, body contouring, and tightening across different areas.

Best of LSM

Apply recent LSM Journal research to improve patient care and outcomes with laser and energy-based treatments.
Explore pre-clinical models for designing and evaluating laser and energy-based devices.

Histology and Imaging of Lasers and Energy-Dased Devices

Analyze the mechanisms of established and emerging lasers and energy-based devices by examining histological evidence and non-invasive skin imaging tools such as optical coherence tomography.
Select safe and effective devices for various clinical indications.
Adjust device settings confidently and efficiently to achieve optimal clinical outcomes.

Nursing/Allied Health

Identify safety equipment and its uses.
Identify and use the LSO in clinical practice.
Identify and utilize ANSI standards in clinical practice.

Criteria for Success

A certificate of completion will be awarded based on the participant's attendance. A certificate of completion will be available upon completion of an online evaluation/claim credit form available at: https://www.akhcme.com/aslms/. Please claim your credit by 2:00 PM EDT on May 28, 2025. If you have questions about this CE activity, please contact AKH Inc at tbrignoni@akhcme.com.

CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American Society for Laser Medicine and Surgery, Inc. (ASLMS). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 12.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing

Credit being awarded: 12.5 ANCC contact hours

California Board of Registered Nursing

In compliance with the Professional Medical Education Association which is accredited with the California Board of Registered Nursing, Provider # CEP 12386, CE Credit hours are calculated as 1 contact hour per 50 minutes of instruction. Courses must not be less than 60 minutes in length and attendees may not claim partial credit.

Commercial Support

There is no commercial support for this activity.

Disclosures

Disclosures All planners and faculty for this educational activity, except for those listed below, have no financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Macrene R Alexiades, MD, PhD, discloses the following financial relationships: Contracted Research - Candela Lasers
R. Rox Anderson, MD, discloses the following financial relationships: Royalty/Patent Beneficiary - Accure Acne, Inc.; Owner/Co-Owner Founder/Co-Founder - Blossom Innovations; Royalty/Patent Beneficiary - Cytrellis Biosystems; Stock Options Holder - Cytrellis Biosystems
Lisa M Arkin, MD, discloses the following financial relationships: Contracted Research - Amgen, Eli Lilly, Merck; Consulting Fees - Merck, NobelPharma, Regeneron/Sanofi
Mathew Avram, MD, JD, discloses the following financial relationships: Consulting Fees - Allergan, Pelage; Royalty/Patent Beneficiary - Cytrellis Biosystems, Inc; Stock Shareholder - Cytrellis Biosystems, Inc
Thomas M. Beachkofsky, MD, discloses the following financial relationships: Travel Support - Acclaro; Consulting Fees, Honoraria, Lumenis Be
Ashish C. Bhatia, MD, FAAD, FASLMS, discloses the following financial relationships: Consulting Fees - Cutera, Inc.; Contracted Research - Cutera, Inc.; Honoraria - Cutera, Inc.; Stock Shareholder - Cutera, Inc.
Brian S Biesman, MD, discloses the following financial relationships: Consulting Fees - AbbVie, Acclaro, Alastin, Canfield, Cytrellis, Galderma, Jetema, Levation, Loreal, Lumenis, Luvo, Merz, Raziel, RBC, Revance, Revelle, Revision, RVL, Solta, Teoxane, xMedica, Zimmer; Contracted Research - AbbVie, Acclaro, Cytrellis, Galderma, Loreal, Merz, Raziel, Revance, Revision, Sofwave, Solta, Teoxane; Honoraria - AbbVie, Galderma, Revance, Revision, Solta; Speakers' Bureau - Galderma, Solta
Jeanette M Black, MD, discloses the following financial relationships: Consulting Fees - Allergan Aesthetics / Abbvie, Calissa Therapeutics, Evolus, Galderma; Honoraria - Allergan Aesthetics / Abbvie, Calissa Therapeutics, Evolus, Galderma; Speakers' Bureau - Allergan Aesthetics / Abbvie, Galderma
A. Jay Burns, MD, discloses the following financial relationships: Speakers' Bureau - Sofwave
Henry Hin Lee Chan, MD, PhD, FRCP, discloses the following financial relationships: Owner/Co-Owner Founder/Co-Founder - AVAVA, LLC, Blossom Innovations, LLC; Honoraria - Boehringer Ingelheim (Hong Kong) Ltd., Cynosure, Cytrellis Biosystems, Inc., Galderma, Massachusetts General Hospital, R2 Technologies, Inc., Sanofi Hong Kong Limited, Sofwave Medical Ltd.; Stock Shareholder - Clarity Cosmetics, Inc., Cytrellis Biosystems, Inc.; Equipment for 6-month trial - Cutera, Inc.; Royalty/Patent Beneficiary - Massachusetts General Hospital; Stock Options Holder - R2 Technologies, Inc.; Support Clinical Trial - R2 Technologies, Inc., Sofwave Medical Ltd.; Free Consumable for Clinical Trial - Cynosure
Anne M Chapas, MD, discloses the following financial relationships: Consulting Fees - Abbvie, Candela, Cutera, Galderma, Lumenis, Sofwave, Teoxane/Revance; Contracted Research - Abbvie, Candela, Cutera, Inmode, Lumenis, Sofwave, Teoxane/Revance
Rishi Chopra, MD, MS, FAAD, discloses the following financial relationships: Consulting Fees - Cutera, Inc., Cynosure/Lutronic, Evolus; Honoraria - Cutera, Inc., Cynosure/Lutronic, Evolus; Speakers' Bureau - Cutera, Inc., Cynosure/Lutronic, Evolus, Sofwave
Hye Jin Chung, MD, MMSc, discloses the following financial relationships: Contracted Research - RecensMedical, Regeneron
Joel L Cohen, MD, FAAD, FACMS, discloses the following financial relationships: Honoraria - BTL Industries
Barry E. DiBernardo, MD, FACS, discloses the following financial relationships: Consulting Fees - Sofwave; Contracted Research - Sofwave
Christine C. Dierickx, MD, discloses the following financial relationships: Consulting Fees - Accure
Catherine M. DiGiorgio, MD, discloses the following financial relationships: Consulting Fees - Alastin Skincare
Jeffrey S. Dover, MD, FRCPC, discloses the following financial relationships: Consulting Fees - AbbVie, Allergan; Contracted Research - Cutera; Unpaid Consulting - Cynosure, Solta Medical
Paul M Friedman, MD, discloses the following financial relationships: Consulting Fees - Acclaro Corp, Allergan, Candela, Cytrellis, Merz Aesthetics, R2 Technologies, Solta Medical; Stock Options Holder - Acclaro Corp; Speakers' Bureau - Candela, Solta Medical
Roy G Geronemus, MD, discloses the following financial relationships: Consulting Fees - Accure, Allergan / Abbvie, Avava, BellaMia, Candela, Cynosure / Lutronic, Cytrellis, Galderma, Novoxel, Sofwave, Solta; Contracted Research - Accure, Allergan / Abbvie, Avava, Candela, Cynosure / Lutronic, Cytrellis, Galderma, New York Stem Cell Foundation, Novoxel, Sofwave, Solta; Stock Shareholder - Accure; Royalty/Patent Beneficiary - Massachusetts General Hospital; Speakers' Bureau - Candela
Michael H. Gold, MD, FAAD, discloses the following financial relationships: Consulting Fees - Aerolase; Honoraria - Aerolase
David J. Goldberg, MD, discloses the following financial relationships: Contracted Research - Cutera
Noelani Gonzalez, MD, discloses the following financial relationships: Consulting Fees - AbbVie, Allergan; Honoraria - AbbVie, Allergan, Alastin Skincare, Elta MD, La Roche-Posay - L'Oreal; Speakers' Bureau - AbbVie, Allergan
Merete Haedersdal, MD, PhD, DMSc, discloses the following financial relationships: Consulting Fees - Procter & Gamble; Contracted Research - La Roche-Posay - L'Oreal, Leo Pharma, Michelson Diagnostics, Venus Concept; Equipment - Cynosure-Lutronic, GME Medical; Research Collaboration - Damae, Michelson Diagnostics; Honoraria - Cynosure-Lutronic, Galderma, La Roche-Posay - L'Oreal
Michelle F. Henry, MD, discloses the following financial relationships: Speakers' Bureau - Allergan, Cynosure, Inmode; Consulting Fees - Elta MD; Consultant - L'oreal
John E. Hoopman, CMLSO, discloses the following financial relationships: Contracted Research - Acclaro, Aliform, Brijjit Medical Inc, Cytrellis, InMode, Sciton, Venus Concept
Jeffrey Hsu, MD, FAAD, discloses the following financial relationships: Consulting Fees: Allergan Aesthetics / Abbvie, ALMA LASERS, Revance Aesthetics, Suneva Medical, Theravant Corp, Honoraria: ALMA LASERS, Suneva Medical; Speakers' Bureau: ALMA LASERS, Revance Aesthetics; Contracted Research: Emblation, Ltd.; Stock Shareholder: Theravant Corp
Omar A. Ibrahimi, MD, PhD, discloses the following financial relationships: Consulting Fees: AbbVie, Accure Acne, Blueberry Therapeutics, Cutera, Cytrellis, Lutronic, Organogenesis, Quthero, Revance, Stock Shareholder: AbbVie, Accure Acne, Anthem, AVAVA Medical, Beam Therapeutics, Blueberry Threapeutics, Crisper Therapeutics, Cutera, Editas, General Electric, Ginkgo Bioworks Holdings, Intellia, Johnson & Johnson, Lutronic, Moderna, Organogenesis, Pfizer, Procter & Gamble, Quthero, Regeneron Pharmaceutical, Revance, Unilever, Vertex Pharmaceuticals, Viatris, Board of Director: Blueberry Therapeutics, Medical Director: Lutronic
Carolyn Jacob, MD, FAAD, discloses the following financial relationships: Consulting Fees: Allergan Aesthetics, BTL Industries, colgate/PCA, Galderma, OneSkin, Ourself by GLO Pharma, Revance, Contracted Research: Allergan Aesthetics, BTL Industries, colgate/PCA, Croma, Eiron, Galderma, Merz, Speakers' Bureau: Galderma, Revance
Faiyaaz A. Kalimullah, MD, discloses the following financial relationships: Speakers' Bureau: Allergan Aesthetics
Arielle N.B. Kauvar, MD, discloses the following financial relationships: Contracted Research: Candela, Sofwave,Consulting Fees: Lumenis, Sofwave
Kristen M. Kelly, MD, discloses the following financial relationships: Contracted Research: Biophotas, FDZJ, Lutronic, Michaelson Diagnostics, Equipment: Lutronic, Michaelson Diagnostics, Consulting Fees: Primus Pharmaceuticals, Equipment provided to clinic: Sciton
Shilpi Khetarpal, MD, discloses the following financial relationships: Consulting Fees: AbbVie, Allergan, Aesthetic Management Partners, crown laboratories, Galderma, musculoskeletal transplant foundation; Speakers' Bureau: Galderma, musculoskeletal transplant foundation; Stock Options Holder: Great Many
Suzanne L. Kilmer, MS, MD, FAAD, discloses the following financial relationships: Consulting Fees: Acclaro, Allergan, BellaMia, BTL, Caliway, Candescent, Cynosure/Lutronic, Cytrellis, Engage Technologies, Galderma, Lumenis, Revance, Sofwave, Solta/Valiant; Research Support: Allergan, BTL, Cynosure/Lutronic, Cytrellis, Loreal, Merz, Revance, Sofwave, Solta/Valiant; Stock Shareholder: Acclaro, Accure, AVAVA, Candescent, Cutera, Engage Technologies, Cytrellis; Stock Options Holder: BellaMia, Engage Technologies
Melanie M. Kingsley, MD, discloses the following financial relationships: Owner/Co-Owner Founder/Co-Founder: SkinTherapyMD
Andrew C. Krakowski, MD, discloses the following financial relationships: Owner/Co-Owner Founder/Co-Founder: conSCIENCE LLC
Tracey L. Mancuso, BSc-HS, CMLSO, discloses the following financial relationships: Consulting Fees: Xcite Tech
Ardalan Minokadeh, MD, PhD, discloses the following financial relationships: Contracted Research: Allergan Aesthetics / Abbvie, Galderma, Consulting Fees: Evolus, Honoraria: Merz Aesthetics
Girish S. Munavalli, MD, MHS, discloses the following financial relationships: Consulting Fees: Candela corp, Honoraria: Candela corp, Sofwave, Speakers' Bureau: Candela corp, Sofwave, Stock Options Holder: Candela corp, Contracted Research: Sofwave
Taryn N. Murray, MD, discloses the following financial relationships: Consulting Fees and Speakers' Bureau: Acclaro
Patti A. Owens, BSN, MHA, RN, CMLSO, CNOR, discloses the following financial relationships: Consulting Fees: Rockwell Laser Industries
Jason N. Pozner, MD, discloses the following financial relationships: Stock Shareholder: avava, cynosure lutronic, sciton, sofwave, Speakers' Bureau: cynosure lutronic, sciton, sofwave, Contracted Research: Innovative Optics, Speakers' Bureau: sciton, sofwave
Thomas E. Rohrer, MD, discloses the following financial relationships: Consulting Fees: Candela, Speakers' Bureau: Candela, Contracted Research: Lumenis
Edward V. Ross, MD, discloses the following financial relationships: Contracted Research: Acclaro, Benev, Cynosure Lutronic, Lumenis, Venus Concepts, Consulting Fees: Cynosure Lutronic, Stock Options Holder: Acclaro, Accure, Honoraria: Agnes Medical, Benev, Loan of Equipment: Cutera
Mona Sadeghpour, MD, discloses the following financial relationships: Honoraria: Solta Medical
Nazanin Saedi, MD, discloses the following financial relationships: Consulting Fees: Galderma
Fernanda H. Sakamoto, MD, PhD, discloses the following financial relationships: Consulting Fees: Accure Acne, Beiersdorf, Owner/Co-Owner Founder/Co-Founder: Lightwater Bioscience Ltd
Elizabeth L. Tanzi, MD, FAAD, discloses the following financial relationships: Contracted Research: BTL Industries
Amy F. Taub, MD FAAD, discloses the following financial relationships: Consulting Fees: AbbVie, Allergan Aesthetics, Stock Shareholder: AbbVie, Speakers' Bureau: Allergan Aesthetics, Contracted Research: Sofwave, Mark B. Taylor, MD, FAAD, discloses the following financial relationships: Honoraria, Discounted Equipment and Speakers' Bureau: Quanta System
Nkemjika Ugonabo, MD, MPH, discloses the following financial relationships: Honoraria: Lutronic
Jill S. Waibel, MD, discloses the following financial relationships: Consulting Fees: Allergan, Candela, Cytrellis Biosystems, Loreal, Lumenis, Procter & Gamble, RegenX, Skinceuticals, Solta, VivoSight; Contracted Research: Amgen, Bellamia, Bristol Meyers Squibb, Candela, Cytrellis Biosystems, Eli Lilly, Emblation, Galderma, Horizon, Incyte, Janssen/JNJ, Lumenis, Neuronetics, Pfizer, RegenX, Sanofi, Sciton, Shanghi Biopharma, PWB, Skinceuticals; Clinical Trial: Candela; Advisory Board: Cytrellis Biosystems; Speakers' Bureau: Eli Lilly, Galderma, Sciton, VivoSight
Jacqueline Watchmaker, MD, discloses the following financial relationships: Consulting Fees: AbbVie, Allergan; Honoraria: AbbVie, Allergan
Mara C. Weinstein Velez, MD, discloses the following financial relationships: Honoraria: Alastin/Galderma
Robert A. Weiss, MD, FAAD, discloses the following financial relationships: Contracted Research: Fotona, LASEROPTEK
Douglas Wu, MD, PhD, discloses the following financial relationships: Consulting Fees: AbbVie, Candela, Cynosure; Honoraria: AbbVie, Candela, Cynosure; Speakers' Bureau: Candela, Cynosure; Contracted Research: Candela, Cynosure

All the relevant financial relationships listed for these individuals have been mitigated.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH and ASLMS planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to optout@akhcme.com with your information with "Opt Out" in the subject line.

* Please note the agenda, faculty, and CE hours are subject to change.